Ireland’s CAR-T milestone highlights growth of advanced therapy capability
St James’s Hospital has treated more than 150 patients with CAR-T therapy since 2021, highlighting Ireland’s expanding advanced therapy capability and specialist infrastructure for complex blood cancer treatment.
Galway implant research advances delivery of next-generation cancer therapies
University of Galway researchers have developed a flexible implant designed to enable repeated local delivery of cell and biologic therapies for ovarian cancer, highlighting Ireland’s growing capability in advanced drug delivery and medical-device innovation.
CAR-T Expansion Signals a New Phase for Ireland’s Advanced Therapies
Ireland’s launch of CAR-T therapy highlights the country’s opportunity to strengthen advanced-therapy capabilities. Growing cell-therapy adoption is creating new opportunities across manufacturing, specialised infrastructure, supply chains, research and pharmaceutical innovation.
SkyCell Announced as Gold Sponsor of the Pharma Industry Awards UK 2026
SkyCell, a Swiss supply chain technology company trusted by the top 20 pharma companies worldwide, has been announced as Gold Sponsor of the Pharma Industry Awards UK 2026, taking place on 23rd September at the Park Plaza London Riverbank.
ABM Announced as Gold Panel Partner for the Life Sciences Industry Conference 2026
ABM, a leading global provider of integrated facility, engineering, and infrastructure solutions with more than 100,000 employees and over $8 billion in annual revenue, has been announced as Gold Panel Partner for the Life Sciences Industry Conference 2026.
Mason Technology Announced as Gold Sponsor of the Pharma Industry Awards 2026
Mason Technology, one of Ireland's leading providers of scientific instrumentation, technical services, and compliance solutions since 1780, has been announced as Gold Sponsor of the Pharma Industry Awards 2026, with winners to be announced on 26th November at the Johnstown Estate Hotel. Supporting Ireland's pharmaceutical and biopharmaceutical industries with advanced technologies, ISO 17025 accredited calibration, and expert validation services, Mason Technology brings over two centuries of scientific expertise and a deep commitment to quality and regulatory compliance to the programme.
Irish API manufacturer expands UK market access through dronabinol launch
Athlone-based Dunbar Pharma has expanded its international pharmaceutical manufacturing footprint, supplying plant-derived dronabinol to the UK through IPS Pharma under the regulated Specials pathway.
Pharma services acquisition preserves specialist drug development capability
TMC Pharma Services’ acquisition of tranScrip preserves around 45 specialist jobs while expanding regulatory, medical and scientific capabilities across the UK, Ireland and wider pharmaceutical development market.
SK Pharmteco expansion strengthens Swords’ advanced pharmaceutical manufacturing capacity
SK Pharmteco’s Swords expansion adds commercial small-molecule and high-container HPAPI capacity, strengthening Ireland’s pharmaceutical manufacturing infrastructure and supporting more complex drug development and commercial supply programmes.
Biologics, GLP-1s and the Working Capital Opportunity Irish Pharma Is Well Placed to Seize
The GLP-1 and biologics boom is stretching pharmaceutical working capital to record levels. For life sciences Ireland, this complexity is an opportunity to lead in supply chain modernisation and manufacturing excellence.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
Sort by



.png)

